BIO

Bio-Rad Laboratories Inc

Sep 17 • 04:00PM ET

280.29

-1.97 -0.70 %

Healthcare • Medical Devices • USA • NYSE

| Held by: VTI IJH VB VBR VXF MDY DFAT IJJ DFSV SPMD

Index	-	P/E	23.89	EPS (ttm)	11.73	Insider Own	32.33%	Shs Outstand	21.99M	Perf Week	1.22%
Market Cap	7.59B	Forward P/E	25.91	EPS next Y	10.82	Insider Trans	-0.03%	Shs Float	18.31M	Perf Month	-1.53%
Enterprise Value	7.62B	PEG	4.69	EPS next Q	1.96	Inst Own	70.80%	Short Float	5.48%	Perf Quarter	21.62%
Income	319.17M	P/S	2.97	EPS this Y	-3.50%	Inst Trans	-1.00%	Short Ratio	3.35	Perf Half Y	7.79%
Sales	2.55B	P/B	1.06	EPS next Y	8.74%	ROA	3.21%	Short Interest	1.00M	Perf YTD	-14.68%
Book/sh	263.42	P/C	5.51	EPS next 5Y	5.09%	ROE	4.59%	52W High	387.99 -27.76%	Perf Year	-14.08%
Cash/sh	50.82	P/FCF	20.45	EPS past 3/5Y	- -	ROIC	3.76%	52W Low	211.43 32.57%	Perf 3Y	-45.34%
Dividend Est.	-	EV/EBITDA	14.86	Sales past 3/5Y	-4.24% 2.11%	Gross Margin	53.52%	Volatility	2.62% 2.81%	Perf 5Y	-44.33%
Dividend TTM	-	EV/Sales	2.98	EPS Y/Y TTM	125.03%	Oper. Margin	12.35%	ATR (14)	8.57	Perf 10Y	101.92%
Dividend Ex-Date	-	Quick Ratio	3.67	Sales Y/Y TTM	-0.33%	Profit Margin	12.50%	RSI (14)	48.24	Recom	1.78
Dividend Gr. 3/5Y	- -	Current Ratio	5.12	EPS Q/Q	115.30%	SMA20	-3.03%	Beta	0.98	Target Price	332.00
Payout	-	Debt/Eq	0.20	Sales Q/Q	2.06%	SMA50	2.57%	Rel Volume	0.85	Prev Close	282.26
Employees	7700	LT Debt/Eq	0.19	Earnings	Jul 31 AMC	SMA200	1.39%	Avg Volume	299.62K	Price	280.29
IPO	Feb 27, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	50.52% 5.92%	Trades		Volume	254,765	Change	-0.70%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy	$350 → $400
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$340
Jun-03-24	Resumed	Jefferies	Hold	$315
Apr-03-24	Downgrade	Citigroup	Buy → Neutral	$400 → $365
Dec-07-23	Initiated	UBS	Buy	$395
Jun-16-23	Initiated	Wells Fargo	Overweight	$550
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$565
Aug-25-22	Initiated	Credit Suisse	Outperform	$715
Jan-28-22	Reiterated	Citigroup	Buy	$915 → $750
Jan-08-20	Initiated	Wells Fargo	Overweight	$430
Jan-07-20	Initiated	Citigroup	Buy	$450
Oct-17-18	Initiated	Goldman	Buy	$350
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight	$335
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy	$220 → $255
Jan-18-17	Initiated	Deutsche Bank	Hold	$195
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy	$150 → $165
Dec-18-09	Initiated	Maxim Group	Buy	$125

Show Previous Ratings

Sep-02-25 08:23AM	Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery? (Insider Monkey)
Sep-01-25 10:17AM	Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now? (Zacks)
Aug-22-25 07:47PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) +6.59%
Aug-13-25 08:41AM	Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge (GlobeNewswire)
Aug-12-25 04:49AM	STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories (GlobeNewswire)
07:48AM	Loading…
Aug-02-25 07:48AM	Bio-Rad (BIO) Beats Q2 Earnings Estimates, Boosts Outlook With Strong Revenue Growth (Insider Monkey)
Aug-01-25 12:31PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) +17.63%
09:00AM	Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025 (Business Wire)
03:39AM	Bio-Rad Laboratories Inc (BIO) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Jul-31-25 05:28PM	Bio-Rad: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Bio-Rad Reports Second-Quarter 2025 Financial Results (Business Wire)
Jul-30-25 09:28AM	Bio-Rad Laboratories Inc (BIO) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
05:08AM	Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic (GlobeNewswire)
Jul-29-25 10:00AM	ADLM announces 2025 Top Corporate Supporter Award recipients and thanks them for their vital backing (PR Newswire)
04:31AM	North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers (GlobeNewswire)
04:02AM	Loading…
04:02AM	Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche (GlobeNewswire)
Jul-28-25 04:15PM	Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations (Business Wire)
Jul-25-25 10:44PM	Bio-Rad Laboratories, Inc. (BIO) Launches New Digital PCR Systems in 2025 (Insider Monkey)
Jul-24-25 10:00AM	Earnings Preview: Bio-Rad Laboratories (BIO) Q2 Earnings Expected to Decline (Zacks)
Jul-17-25 04:15PM	Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025 (Business Wire)
Jul-16-25 04:07AM	Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific (GlobeNewswire)
Jul-14-25 08:07AM	Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms (Zacks)
Jul-11-25 04:02AM	Ultrasensitive Molecular Amplification Market Research 2025-2035 \| Demand Surges for Early Detection, Molecular Amplification Techniques Lead the Way (GlobeNewswire)
Jul-10-25 05:19AM	New Strong Sell Stocks for July 10th (Zacks)
Jul-07-25 09:00AM	Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout (Business Wire)
Jun-16-25 08:30AM	Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence? (Zacks)
May-29-25 04:30PM	Bio-Rads Management to Host Investor Meetings During Jefferies Global Healthcare Conference (Business Wire)
May-13-25 09:16AM	Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends (Zacks)
May-12-25 04:30PM	Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference (Business Wire) +7.54%
May-03-25 08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
06:48PM	Loading…
May-02-25 06:48PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
07:58AM	BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket (Zacks)
May-01-25 10:35PM	Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:40PM	Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates (Zacks)
04:15PM	Bio-Rad Reports First-Quarter 2025 Financial Results (Business Wire)
Apr-29-25 12:59PM	Bio-Rad Laboratories, Inc. (BIO): Among Billionaire Mason Hawkins' Small-Cap Stocks with Huge Upside Potential (Insider Monkey)
Apr-24-25 10:35AM	Ariel Appreciation Fund Q1 2025 Commentary (Seeking Alpha)
10:25AM	Ariel Focus Fund Q1 2025 Commentary (Seeking Alpha)
10:01AM	Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-23-25 06:00AM	Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types (GlobeNewswire)
Apr-22-25 08:09AM	Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile? (Insider Monkey)
Apr-21-25 08:08AM	Should You be Optimistic on Bio-Rad Laboratories's (BIO) Outlook? (Insider Monkey)
Apr-15-25 09:50PM	Parnassus Value Select ETF Q1 2025 Commentary (Seeking Alpha)
04:15PM	Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 (Business Wire)
Apr-13-25 12:48PM	Longleaf Partners Global Fund Q1 2025 Commentary (Seeking Alpha)
09:51AM	Longleaf Partners Fund Q1 2025 Commentary (Seeking Alpha)
Apr-10-25 01:29PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) -6.77%
Apr-04-25 08:28PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
Apr-03-25 09:00AM	Should You Continue to Hold Bio-Rad Stock in Your Portfolio? (Zacks)
Mar-31-25 10:00AM	Bio-Techne Opens New Customer Experience Centre in Germany (Zacks)
09:20AM	Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate (Zacks)
Mar-24-25 04:05PM	Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts (GlobeNewswire)
Mar-21-25 06:34AM	Why Impact Biomedical Inc. (IBO) Surged On Thursday? (InsiderMonkey)
Mar-17-25 05:29PM	Alger Russell Innovation Index Updates for First Quarter 2025 (PR Newswire)
Feb-15-25 10:05AM	Bio-Rad price target lowered to $447 from $477 at RBC Capital (TipRanks)
Feb-14-25 05:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research) -9.53%
12:07PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
Feb-13-25 04:20PM	Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results (Business Wire)
04:15PM	Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies (Business Wire)
Feb-11-25 08:46AM	OncoCyte prices $29.1M equity offering (TipRanks)
Feb-10-25 08:30AM	Oncocyte Prices $29.1 Million Equity Offering (GlobeNewswire)
Jan-27-25 05:00PM	Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 (Business Wire)
Jan-08-25 08:15AM	Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests (Business Wire)
Jan-02-25 04:30PM	Bio-Rads Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference (Business Wire)
Nov-24-24 08:05PM	Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory (Insider Monkey)
Nov-21-24 09:00AM	Bio-Rads Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference (Business Wire)
Oct-31-24 11:52AM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research) +8.35%
09:00AM	Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference (Business Wire)
Oct-30-24 04:15PM	Bio-Rad Reports Third-Quarter 2024 Financial Results (Business Wire)
Oct-14-24 05:30PM	Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024 (Business Wire)
Sep-23-24 07:45AM	5 Things to Know Before the Stock Market Opens (Investopedia)
Sep-22-24 06:00AM	Palantir and Dell Are Set to Join the S&P 500 Monday. Here's What That Means. (Investopedia)
Sep-19-24 04:20PM	What Friday's Triple-Witching Means For You (Investopedia)
Sep-09-24 10:56AM	Palantir and Dell Will Join S&P 500 What You Need To Know (Investopedia)
Sep-06-24 06:43PM	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Aug-28-24 05:25PM	S&P 500 Gains and Losses Today: Supermicro Stock Plunges on Annual Report Delay (Investopedia)
Aug-22-24 04:30PM	Bio-Rads Management to Participate in Fireside Chat During Wells Fargos 2024 Healthcare Conference (Business Wire)
Aug-20-24 08:30AM	Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer (Business Wire)
Aug-01-24 04:15PM	Bio-Rad Reports Second-Quarter 2024 Financial Results (Business Wire)
Jul-17-24 04:30PM	Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024 (Business Wire) -5.77%
Jun-21-24 08:30AM	Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now? (Zacks)
Jun-14-24 04:35AM	Is Bio-Rad Laboratories (BIO) a Lucrative Investment? (Insider Monkey)
Jun-06-24 11:31AM	Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report? (Zacks)
May-30-24 09:00AM	Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group (Business Wire)
May-23-24 04:15PM	Bio-Rads Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference (Business Wire)
May-08-24 01:52PM	Analyst Report: Bio-Rad Laboratories, Inc. (Morningstar Research)
12:17PM	Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down (Zacks)
09:03AM	Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 05:30PM	Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates (Zacks)
04:15PM	Bio-Rad Reports First-Quarter 2024 Financial Results (Business Wire)
May-04-24 12:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
May-03-24 12:15PM	Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 (PR Newswire)
May-01-24 09:00AM	Bio-Rads Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference (Business Wire)
Apr-30-24 10:00AM	Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-26-24 08:30AM	Bio-Rad Announces Life Science Group Management Changes (Business Wire)
Apr-18-24 10:03AM	Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits? (Zacks)
09:00AM	Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 (Business Wire)
Apr-16-24 10:56AM	Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition (Zacks)
Apr-11-24 05:30PM	Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay (GlobeNewswire) -5.81%
Apr-10-24 04:15PM	Bio-Rads Chief Operating Officer Andrew Last to Retire (Business Wire)

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EVRAN SEDAT	EVP, Global Supply Chain	Sep 06 '25	Option Exercise	0.00	864	0	1,801	Sep 09 04:24 PM
Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Sep 06 '25	Option Exercise	0.00	1,535	0	2,394	Sep 09 04:23 PM
COREY COLLEEN	EVP, Global Human Resources	Sep 06 '25	Option Exercise	0.00	576	0	19,759	Sep 09 04:23 PM
BARRY JAMES	EVP, President, LSG	Sep 06 '25	Option Exercise	0.00	1,056	0	1,588	Sep 09 04:22 PM
Allison Schwartz	Director	Sep 06 '25	Option Exercise	0.00	92	0	1,489	Sep 09 04:21 PM
ENGELHARDT EVA ANETTE	EVP, President, CDG	Sep 06 '25	Option Exercise	0.00	1,152	0	1,309	Sep 09 04:21 PM
ENLOE COURTNEY C	EVP, General Counsel & Sec	Sep 06 '25	Option Exercise	0.00	768	0	904	Sep 09 04:20 PM
SCHWARTZ NORMAN D	Chairman & CEO	Sep 06 '25	Option Exercise	0.00	3,455	0	444,962	Sep 09 04:19 PM
Allison Schwartz	Director	Sep 01 '25	Option Exercise	0.00	147	0	1,452	Sep 03 06:03 PM
BARRY JAMES	EVP, President, LSG	Sep 01 '25	Option Exercise	0.00	602	0	749	Sep 03 06:03 PM
COREY COLLEEN	EVP, Global Human Resources	Sep 01 '25	Option Exercise	0.00	1,102	0	19,581	Sep 03 06:02 PM
SCHWARTZ NORMAN D	Chairman & CEO	Sep 01 '25	Option Exercise	0.00	6,353	0	444,591	Sep 03 06:00 PM
MICHAEL W CROWLEY	Officer	Aug 05 '25	Proposed Sale	275.92	1,488	410,572		Aug 05 04:47 PM
ENGELHARDT EVA ANETTE	EVP, President, CDG	Jul 25 '25	Option Exercise	0.00	245	0	245	Jul 29 05:20 PM
Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Apr 24 '25	Option Exercise	0.00	1,077	0	1,231	Apr 25 06:07 PM
ENLOE COURTNEY C	EVP, General Counsel & Sec	Apr 24 '25	Option Exercise	0.00	186	0	196	Apr 25 06:06 PM
PINKSTON ARNOLD A	Director	Apr 22 '25	Option Exercise	0.00	308	0	308	Apr 24 05:15 PM
PEI MELINDA LITHERLAND	Director	Apr 22 '25	Option Exercise	0.00	308	0	308	Apr 24 05:14 PM
HINCKLEY GREGORY K	Director	Apr 22 '25	Option Exercise	0.00	308	0	308	Apr 24 05:14 PM
EDWARDS JEFFREY L	Director	Apr 22 '25	Option Exercise	0.00	308	0	308	Apr 24 05:13 PM
Crowley Michael	EVP, GBL Commercial Operations	Mar 14 '25	Option Exercise	159.32	3,000	477,960	11,171	Mar 18 04:36 PM
Crowley Michael	EVP, GBL Commercial Operations	Mar 14 '25	Sale	247.06	3,000	741,184	8,171	Mar 18 04:36 PM
Crowley Michael	Officer	Mar 13 '25	Proposed Sale	260.00	3,000	780,000		Mar 13 05:17 PM
Alles Institute for Medical Re	Director	Mar 11 '25	Proposed Sale	247.66	410	101,540		Mar 11 12:36 PM
Last Andrew J.	Officer	Nov 06 '24	Proposed Sale	373.64	3,000	1,120,934		Nov 06 06:26 PM
EVRAN SEDAT	EVP, Global Supply Chain	Oct 20 '24	Option Exercise	0.00	1,044	0	1,188	Oct 22 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BIO

Bio-Rad Laboratories Inc

Upgrade your FINVIZ experience